On Feb. 26, 2014, Japan MHLW revised some provisions of the Post-Market Safety Management Standards for Pharmaceuticals, Quasi Drugs, Cosmetics and Medical Devices: Report on Side Effects of Quasi-Drugs and Cosmetics.
The standards specify the legal basis, terminologies, deadline, format and etc. of adverse reaction reports.
Original regulatory document


Request a Demo
